Doesn’t surprise me at all.
Injectable technology is far beyond the old RFID chips. The new injectable tech is micropscopic in size.
Here’s just one example:
“Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technology”
“...The project is part of DARPA’s SIGMA+ program in the Defense Sciences Office (DSO)...”
https://profusa.com/profusa-and-partners-announce/
5/27/21
“Healthcare Automatic Identification And Data Capture Market Size Worth $62.0 Billion By 2028: Grand View Research, Inc.”
“SAN FRANCISCO, May 27, 2021 /PRNewswire/ — The global healthcare automatic identification and data capture market size is expected to reach USD 62.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 22.3% from 2021 to 2028. The growth is attributed majorly due to the increasing focus of pharmaceutical companies on optimizing the supply chain. For instance, in October 2020, Sandoz launched its first RFID-tagged critical injectable medicines in the U.S...”
December 17, 2020
“How DARPA seeded the ground for a rapid COVID-19 cure”
“SEANA SMITH: As Pfizer’s vaccine starts to get distributed this week, and also as we prepare for Moderna potentially being next in line, we want to talk about— or take a look, I should say, at the role that a US defense agency played in preparing the US to produce a vaccine very quickly. And for that, we want to bring in Regina Dugan. She’s the former head of DARPA...”
“...Regina, let me just start with the fact that— I guess explain to us how DARPA’s investments over the last several years, going back even more than a decade or so, have helped accelerate the pace that we have seen for a COVID vaccine and have gotten us to this point that we’ve been able to get to so quickly...”
https://finance.yahoo.com/video/darpa-seeded-ground-rapid-covid-214655580.html